This research traces the history of the first clinical applications for robotic devices and all associated technology required to create a true robotic-assisted surgical device (RASD). The study examines the people (leaders) and entities that became pioneers and founders of the RASD industry vertical. With fundamental original equipment manufacturers (OEM) in place, we investigated which companies profited and how they profited. This research service concludes with a presentation of 3 possible scenarios for the development and proliferation of a third generation of RASDs.

This study will assist healthcare providers, hospitals, and health systems in assessing how to increase strategically and economically the number of robot-assisted surgeries as a percentage of total facility surgeries.

Analysis of the subject matter results in presentation-feasible robot-assisted technology research and development (R&D) over the immediate future, where capitalization is centered, and how RASD OEMs hope to capture market share.

Moreover, this study extrapolates the current industry vertical for robot-assisted surgery applications to a broadened value-based reimbursement surgical continuum by examining how robot-assisted surgery fits or does not fit in current Centers for Medicare & Medicaid Services (CMS) pilot studies (Comprehensive Care for Joint Replacement). Lastly, this study positions readers to adapt their current relationship with robot-assisted surgery by better understanding the sustainable business model created by Intuitive Surgical, Inc. (da Vinci®) and how this company has achieved 100% market share for over a decade.